Expression of GLP-1 receptors in insulin-containing interneurons of rat cerebral cortex

Éva A. Csajbók, Ágnes K. Kocsis, Nóra Faragó, Szabina Furdan, Balázs Kovács, Sándor Lovas, G. Molnár, István Likó, A. Zvara, L. Puskás, A. Patócs, G. Tamás

Research output: Contribution to journalArticle

Abstract

Aims/hypothesis: Glucagon-like peptide 1 (GLP-1) receptors are expressed by pancreatic beta cells and GLP-1 receptor signalling promotes insulin secretion. GLP-1 receptor agonists have neural effects and are therapeutically promising for mild cognitive impairment and Alzheimer’s disease. Our previous results showed that insulin is released by neurogliaform neurons in the cerebral cortex, but the expression of GLP-1 receptors on insulin-producing neocortical neurons has not been tested. In this study, we aimed to determine whether GLP-1 receptors are present in insulin-containing neurons. Methods: We harvested the cytoplasm of electrophysiologically and anatomically identified neurogliaform interneurons during patch-clamp recordings performed in slices of rat neocortex. Using single-cell digital PCR, we determined copy numbers of Glp1r mRNA and other key genes in neurogliaform cells harvested in conditions corresponding to hypoglycaemia (0.5 mmol/l glucose) and hyperglycaemia (10 mmol/l glucose). In addition, we performed whole-cell patch-clamp recordings on neurogliaform cells to test the effects of GLP-1 receptor agonists for functional validation of single-cell digital PCR results. Results: Single-cell digital PCR revealed GLP-1 receptor expression in neurogliaform cells and showed that copy numbers of mRNA of the Glp1r gene in hyperglycaemia exceeded those in hypoglycaemia by 9.6 times (p < 0.008). Moreover, single-cell digital PCR confirmed co-expression of Glp1r and Ins2 mRNA in neurogliaform cells. Functional expression of GLP-1 receptors was confirmed with whole-cell patch-clamp electrophysiology, showing a reversible effect of GLP-1 on neurogliaform cells. This effect was prevented by pre-treatment with the GLP-1 receptor-specific antagonist exendin-3(9-39) and was absent in hypoglycaemia. In addition, single-cell digital PCR of neurogliaform cells revealed that the expression of transcription factors (Pdx1, Isl1, Mafb) are important in beta cell development. Conclusions/interpretation: Our results provide evidence for the functional expression of GLP-1 receptors in neurons known to release insulin in the cerebral cortex. Hyperglycaemia increases the expression of GLP-1 receptors in neurogliaform cells, suggesting that endogenous incretins and therapeutic GLP-1 receptor agonists might have effects on these neurons, similar to those in pancreatic beta cells.

Original languageEnglish
JournalDiabetologia
DOIs
Publication statusAccepted/In press - Jan 1 2019

Fingerprint

Interneurons
Cerebral Cortex
Insulin
Neurons
Polymerase Chain Reaction
Hypoglycemia
Hyperglycemia
Insulin-Secreting Cells
Glucagon-Like Peptide-1 Receptor
Messenger RNA
Incretins
Glucose
Glucagon-Like Peptide 1
Electrophysiology
Neocortex
Genes
Alzheimer Disease
Cytoplasm

Keywords

  • Animal
  • Basic science
  • Gastro-entero pancreatic factors
  • Hormone receptors
  • Other techniques
  • Rat

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Csajbók, É. A., Kocsis, Á. K., Faragó, N., Furdan, S., Kovács, B., Lovas, S., ... Tamás, G. (Accepted/In press). Expression of GLP-1 receptors in insulin-containing interneurons of rat cerebral cortex. Diabetologia. https://doi.org/10.1007/s00125-018-4803-z

Expression of GLP-1 receptors in insulin-containing interneurons of rat cerebral cortex. / Csajbók, Éva A.; Kocsis, Ágnes K.; Faragó, Nóra; Furdan, Szabina; Kovács, Balázs; Lovas, Sándor; Molnár, G.; Likó, István; Zvara, A.; Puskás, L.; Patócs, A.; Tamás, G.

In: Diabetologia, 01.01.2019.

Research output: Contribution to journalArticle

Csajbók, Éva A. ; Kocsis, Ágnes K. ; Faragó, Nóra ; Furdan, Szabina ; Kovács, Balázs ; Lovas, Sándor ; Molnár, G. ; Likó, István ; Zvara, A. ; Puskás, L. ; Patócs, A. ; Tamás, G. / Expression of GLP-1 receptors in insulin-containing interneurons of rat cerebral cortex. In: Diabetologia. 2019.
@article{0b8eb6644fe749349f0c0b290fde71fa,
title = "Expression of GLP-1 receptors in insulin-containing interneurons of rat cerebral cortex",
abstract = "Aims/hypothesis: Glucagon-like peptide 1 (GLP-1) receptors are expressed by pancreatic beta cells and GLP-1 receptor signalling promotes insulin secretion. GLP-1 receptor agonists have neural effects and are therapeutically promising for mild cognitive impairment and Alzheimer’s disease. Our previous results showed that insulin is released by neurogliaform neurons in the cerebral cortex, but the expression of GLP-1 receptors on insulin-producing neocortical neurons has not been tested. In this study, we aimed to determine whether GLP-1 receptors are present in insulin-containing neurons. Methods: We harvested the cytoplasm of electrophysiologically and anatomically identified neurogliaform interneurons during patch-clamp recordings performed in slices of rat neocortex. Using single-cell digital PCR, we determined copy numbers of Glp1r mRNA and other key genes in neurogliaform cells harvested in conditions corresponding to hypoglycaemia (0.5 mmol/l glucose) and hyperglycaemia (10 mmol/l glucose). In addition, we performed whole-cell patch-clamp recordings on neurogliaform cells to test the effects of GLP-1 receptor agonists for functional validation of single-cell digital PCR results. Results: Single-cell digital PCR revealed GLP-1 receptor expression in neurogliaform cells and showed that copy numbers of mRNA of the Glp1r gene in hyperglycaemia exceeded those in hypoglycaemia by 9.6 times (p < 0.008). Moreover, single-cell digital PCR confirmed co-expression of Glp1r and Ins2 mRNA in neurogliaform cells. Functional expression of GLP-1 receptors was confirmed with whole-cell patch-clamp electrophysiology, showing a reversible effect of GLP-1 on neurogliaform cells. This effect was prevented by pre-treatment with the GLP-1 receptor-specific antagonist exendin-3(9-39) and was absent in hypoglycaemia. In addition, single-cell digital PCR of neurogliaform cells revealed that the expression of transcription factors (Pdx1, Isl1, Mafb) are important in beta cell development. Conclusions/interpretation: Our results provide evidence for the functional expression of GLP-1 receptors in neurons known to release insulin in the cerebral cortex. Hyperglycaemia increases the expression of GLP-1 receptors in neurogliaform cells, suggesting that endogenous incretins and therapeutic GLP-1 receptor agonists might have effects on these neurons, similar to those in pancreatic beta cells.",
keywords = "Animal, Basic science, Gastro-entero pancreatic factors, Hormone receptors, Other techniques, Rat",
author = "Csajb{\'o}k, {{\'E}va A.} and Kocsis, {{\'A}gnes K.} and N{\'o}ra Farag{\'o} and Szabina Furdan and Bal{\'a}zs Kov{\'a}cs and S{\'a}ndor Lovas and G. Moln{\'a}r and Istv{\'a}n Lik{\'o} and A. Zvara and L. Pusk{\'a}s and A. Pat{\'o}cs and G. Tam{\'a}s",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/s00125-018-4803-z",
language = "English",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - Expression of GLP-1 receptors in insulin-containing interneurons of rat cerebral cortex

AU - Csajbók, Éva A.

AU - Kocsis, Ágnes K.

AU - Faragó, Nóra

AU - Furdan, Szabina

AU - Kovács, Balázs

AU - Lovas, Sándor

AU - Molnár, G.

AU - Likó, István

AU - Zvara, A.

AU - Puskás, L.

AU - Patócs, A.

AU - Tamás, G.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Aims/hypothesis: Glucagon-like peptide 1 (GLP-1) receptors are expressed by pancreatic beta cells and GLP-1 receptor signalling promotes insulin secretion. GLP-1 receptor agonists have neural effects and are therapeutically promising for mild cognitive impairment and Alzheimer’s disease. Our previous results showed that insulin is released by neurogliaform neurons in the cerebral cortex, but the expression of GLP-1 receptors on insulin-producing neocortical neurons has not been tested. In this study, we aimed to determine whether GLP-1 receptors are present in insulin-containing neurons. Methods: We harvested the cytoplasm of electrophysiologically and anatomically identified neurogliaform interneurons during patch-clamp recordings performed in slices of rat neocortex. Using single-cell digital PCR, we determined copy numbers of Glp1r mRNA and other key genes in neurogliaform cells harvested in conditions corresponding to hypoglycaemia (0.5 mmol/l glucose) and hyperglycaemia (10 mmol/l glucose). In addition, we performed whole-cell patch-clamp recordings on neurogliaform cells to test the effects of GLP-1 receptor agonists for functional validation of single-cell digital PCR results. Results: Single-cell digital PCR revealed GLP-1 receptor expression in neurogliaform cells and showed that copy numbers of mRNA of the Glp1r gene in hyperglycaemia exceeded those in hypoglycaemia by 9.6 times (p < 0.008). Moreover, single-cell digital PCR confirmed co-expression of Glp1r and Ins2 mRNA in neurogliaform cells. Functional expression of GLP-1 receptors was confirmed with whole-cell patch-clamp electrophysiology, showing a reversible effect of GLP-1 on neurogliaform cells. This effect was prevented by pre-treatment with the GLP-1 receptor-specific antagonist exendin-3(9-39) and was absent in hypoglycaemia. In addition, single-cell digital PCR of neurogliaform cells revealed that the expression of transcription factors (Pdx1, Isl1, Mafb) are important in beta cell development. Conclusions/interpretation: Our results provide evidence for the functional expression of GLP-1 receptors in neurons known to release insulin in the cerebral cortex. Hyperglycaemia increases the expression of GLP-1 receptors in neurogliaform cells, suggesting that endogenous incretins and therapeutic GLP-1 receptor agonists might have effects on these neurons, similar to those in pancreatic beta cells.

AB - Aims/hypothesis: Glucagon-like peptide 1 (GLP-1) receptors are expressed by pancreatic beta cells and GLP-1 receptor signalling promotes insulin secretion. GLP-1 receptor agonists have neural effects and are therapeutically promising for mild cognitive impairment and Alzheimer’s disease. Our previous results showed that insulin is released by neurogliaform neurons in the cerebral cortex, but the expression of GLP-1 receptors on insulin-producing neocortical neurons has not been tested. In this study, we aimed to determine whether GLP-1 receptors are present in insulin-containing neurons. Methods: We harvested the cytoplasm of electrophysiologically and anatomically identified neurogliaform interneurons during patch-clamp recordings performed in slices of rat neocortex. Using single-cell digital PCR, we determined copy numbers of Glp1r mRNA and other key genes in neurogliaform cells harvested in conditions corresponding to hypoglycaemia (0.5 mmol/l glucose) and hyperglycaemia (10 mmol/l glucose). In addition, we performed whole-cell patch-clamp recordings on neurogliaform cells to test the effects of GLP-1 receptor agonists for functional validation of single-cell digital PCR results. Results: Single-cell digital PCR revealed GLP-1 receptor expression in neurogliaform cells and showed that copy numbers of mRNA of the Glp1r gene in hyperglycaemia exceeded those in hypoglycaemia by 9.6 times (p < 0.008). Moreover, single-cell digital PCR confirmed co-expression of Glp1r and Ins2 mRNA in neurogliaform cells. Functional expression of GLP-1 receptors was confirmed with whole-cell patch-clamp electrophysiology, showing a reversible effect of GLP-1 on neurogliaform cells. This effect was prevented by pre-treatment with the GLP-1 receptor-specific antagonist exendin-3(9-39) and was absent in hypoglycaemia. In addition, single-cell digital PCR of neurogliaform cells revealed that the expression of transcription factors (Pdx1, Isl1, Mafb) are important in beta cell development. Conclusions/interpretation: Our results provide evidence for the functional expression of GLP-1 receptors in neurons known to release insulin in the cerebral cortex. Hyperglycaemia increases the expression of GLP-1 receptors in neurogliaform cells, suggesting that endogenous incretins and therapeutic GLP-1 receptor agonists might have effects on these neurons, similar to those in pancreatic beta cells.

KW - Animal

KW - Basic science

KW - Gastro-entero pancreatic factors

KW - Hormone receptors

KW - Other techniques

KW - Rat

UR - http://www.scopus.com/inward/record.url?scp=85059938735&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059938735&partnerID=8YFLogxK

U2 - 10.1007/s00125-018-4803-z

DO - 10.1007/s00125-018-4803-z

M3 - Article

AN - SCOPUS:85059938735

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

ER -